Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Anal intercourse, HIV-1 risk, and efficacy in a trial of a dapivirine-containing vaginal ring for HIV-1 prevention.

Peebles K, van der Straten A, Palanee-Phillips T, Reddy K, Hillier SL, Hendrix CW, Harkoo I, Mirembe BG, Jeenarain N, Baeten JM, Brown ER.

J Acquir Immune Defic Syndr. 2019 Dec 3. doi: 10.1097/QAI.0000000000002253. [Epub ahead of print]

PMID:
31809308
2.

Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products.

Minnis AM, Montgomery ET, Napierala S, Browne EN, van der Straten A.

J Acquir Immune Defic Syndr. 2019 Dec;82 Suppl 3:S222-S229. doi: 10.1097/QAI.0000000000002215.

PMID:
31764258
3.

Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis.

Griffin JB, Ridgeway K, Montgomery E, Torjesen K, Clark R, Peterson J, Baggaley R, van der Straten A.

PLoS One. 2019 Nov 8;14(11):e0224898. doi: 10.1371/journal.pone.0224898. eCollection 2019.

4.

Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment.

Browne EN, Montgomery ET, Mansfield C, Boeri M, Mange B, Beksinska M, Schwartz JL, Clark MR, Doncel GF, Smit J, Chirenje ZM, van der Straten A.

AIDS Behav. 2019 Nov 6. doi: 10.1007/s10461-019-02715-1. [Epub ahead of print]

PMID:
31696371
5.

Increases in HIV Incidence Following Receptive Anal Intercourse Among Women: A Systematic Review and Meta-analysis.

Stannah J, Silhol R, Elmes J, Owen B, Shacklett BL, Anton P, McGowan I, van der Straten A, Dimitrov D, Baggaley RF, Boily MC.

AIDS Behav. 2019 Sep 4. doi: 10.1007/s10461-019-02651-0. [Epub ahead of print]

6.

Engaging study participants in interpreting results: lessons from the TRIO study in Kenya and South Africa.

Agot K, Minnis AM, Manenzhe K, Browne EN, Ahmed K, Okello T, van der Straten A.

Int J Womens Health. 2019 Jul 12;11:395-403. doi: 10.2147/IJWH.S193905. eCollection 2019.

7.

HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.

Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi EA, McConnell M, Barnabas RV, Bekker LG.

J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25298. doi: 10.1002/jia2.25298.

8.

Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP).

Johnson LM, Krovi SA, Li L, Girouard N, Demkovich ZR, Myers D, Creelman B, van der Straten A.

Pharmaceutics. 2019 Jul 4;11(7). pii: E315. doi: 10.3390/pharmaceutics11070315.

9.

Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.

Weinrib R, Browne EN, Shapley-Quinn MK, van der Straten A, Beksinska M, Mgodi N, Musara P, Mphili N, Schwartz JL, Ju S, Hanif H, Montgomery ET; Quatro Study Team.

AIDS Behav. 2019 Jun 28. doi: 10.1007/s10461-019-02576-8. [Epub ahead of print]

PMID:
31254190
10.

End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study.

Montgomery ET, Beksinska M, Mgodi N, Schwartz J, Weinrib R, Browne EN, Mphili N, Musara P, Jaggernath M, Ju S, Smit J, Chirenje ZM, Doncel GF, van der Straten A.

J Int AIDS Soc. 2019 May;22(5):e25283. doi: 10.1002/jia2.25283.

11.

"The state of mind tells me it's dirty": menstrual shame amongst women using a vaginal ring in Sub Saharan Africa.

Duby Z, Katz A, Musara P, Nabukeera J, Zimba CC, Woeber K, Palanee-Phillips T, van der Straten A.

Women Health. 2020 Jan;60(1):72-86. doi: 10.1080/03630242.2019.1607803. Epub 2019 May 1.

PMID:
31043134
12.

Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe.

Duby Z, Katz AWK, Browne EN, Mutero P, Etima J, Zimba CC, Woeber K, Atujuna M, Reddy K, van der Straten A; MTN-020/ASPIRE Study Team.

AIDS Behav. 2019 Apr 27. doi: 10.1007/s10461-019-02514-8. [Epub ahead of print]

PMID:
31030301
13.

Two Birds with One Stone: Health Care Providers' Perspectives about Prevention Technologies in Kenya and South Africa.

Lutnick A, Shapley-Quinn MK, Manenzhe KN, Onyango J, Agot K, Ahmed K, van der Straten A.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219841366. doi: 10.1177/2325958219841366.

14.

What Proportion of Female Sex Workers Practise anal Intercourse and How Frequently? A Systematic Review and Meta-analysis.

Owen BN, Baggaley RF, Elmes J, Harvey A, Shubber Z, Butler AR, Silhol R, Anton P, Shacklett B, van der Straten A, Boily MC.

AIDS Behav. 2019 Apr 5. doi: 10.1007/s10461-019-02477-w. [Epub ahead of print] Review.

15.

Design of an Implant for Long-Acting HIV Pre-Exposure Prophylaxis: Input from South African Health Care Providers.

Krogstad EA, Montgomery ET, Atujuna M, Minnis AM, O'Rourke S, Ahmed K, Bekker LG, van der Straten A.

AIDS Patient Care STDS. 2019 Apr;33(4):157-166. doi: 10.1089/apc.2018.0177.

PMID:
30932697
16.

The Invisible Product: Preferences for Sustained-Release, Long-Acting Pre-exposure Prophylaxis to HIV Among South African Youth.

Montgomery ET, Atujuna M, Krogstad E, Hartmann M, Ndwayana S, OʼRourke S, Bekker LG, van der Straten A, Minnis AM.

J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):542-550. doi: 10.1097/QAI.0000000000001960.

PMID:
30865050
17.

First Impressions Matter: How Initial Worries Influence Adherence to the Dapivirine Vaginal Ring.

van der Straten A, Browne EN, Shapley-Quinn MK, Brown ER, Reddy K, Scheckter R, Soto-Torres L, Palanee-Phillips T, Baeten JM, Mensch B; MTN-020/ASPIRE Study Team.

J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):304-310. doi: 10.1097/QAI.0000000000002028.

PMID:
30844995
18.

"We are not the same": African women's view of multipurpose prevention products in the TRIO clinical study.

Shapley-Quinn MK, Manenzhe KN, Agot K, Minnis AM, van der Straten A.

Int J Womens Health. 2019 Feb 7;11:97-107. doi: 10.2147/IJWH.S185712. eCollection 2019.

19.

Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence.

Katz AWK, Mensch BS, Woeber K, Musara P, Etima J, van der Straten A.

BMC Womens Health. 2019 Jan 25;19(1):18. doi: 10.1186/s12905-019-0713-6.

20.

Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa.

Chitukuta M, Duby Z, Katz A, Nakyanzi T, Reddy K, Palanee-Phillips T, Tembo T, Etima J, Musara P, Mgodi NM, van der Straten A; MTN-020/ASPIRE Study Team.

Cult Health Sex. 2019 Nov;21(11):1209-1224. doi: 10.1080/13691058.2018.1552989. Epub 2019 Jan 18.

PMID:
30657023
21.

Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa.

Minnis AM, Browne EN, Boeri M, Agot K, van der Straten A, Ahmed K, Weinrib R, Mansfield C.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):394-403. doi: 10.1097/QAI.0000000000001945.

22.

Perceptions of the "Fabric" - An exploratory study of a novel multi-purpose technology among women in Sub Saharan Africa.

Laborde ND, Leslie J, Krogstad E, Morar N, Mutero P, Etima J, Woodrow K, van der Straten A.

PLoS One. 2018 Oct 31;13(10):e0204821. doi: 10.1371/journal.pone.0204821. eCollection 2018.

23.

Methods for Assessing the Adherence to Medical Devices [Internet].

Johnson LM, Swarner SL, van der Straten A, Rothrock GD.

Research Triangle Park (NC): RTI Press; 2016 Oct.

24.

Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.

Chen BA, Zhang J, Gundacker HM, Hendrix CW, Hoesley CJ, Salata RA, Dezzutti CS, van der Straten A, Hall WB, Jacobson CE, Johnson S, McGowan I, Nel AM, Soto-Torres L, Marzinke MA; MTN-024/IPM 031 Protocol Team for the Microbicide Trials Network .

Clin Infect Dis. 2019 Mar 19;68(7):1144-1151. doi: 10.1093/cid/ciy654.

25.

Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE.

Mensch BS, Richardson BA, Husnik M, Brown ER, Kiweewa FM, Mayo AJ, Baeten JM, Palanee-Phillips T, van der Straten A; MTN-020/ASPIRE study team.

AIDS Behav. 2019 Feb;23(2):504-512. doi: 10.1007/s10461-018-2261-8.

PMID:
30218318
26.

Does per-act HIV-1 transmission risk through anal sex vary by gender? An updated systematic review and meta-analysis.

Baggaley RF, Owen BN, Silhol R, Elmes J, Anton P, McGowan I, van der Straten A, Shacklett B, Dang Q, Swann EM, Bolton DL, Boily MC.

Am J Reprod Immunol. 2018 Nov;80(5):e13039. doi: 10.1111/aji.13039. Epub 2018 Sep 2.

27.

Perspectives of South African youth in the development of an implant for HIV prevention.

Krogstad EA, Atujuna M, Montgomery ET, Minnis A, Ndwayana S, Malapane T, Shapley-Quinn MK, Manenzhe K, Bekker LG, van der Straten A.

J Int AIDS Soc. 2018 Aug;21(8):e25170. doi: 10.1002/jia2.25170.

28.

Long-Term Effects of Cognitive Behavioral Therapy on Planning and Prefrontal Cortex Function in Pediatric Obsessive-Compulsive Disorder.

van der Straten A, Huyser C, Wolters L, Denys D, van Wingen G.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Apr;3(4):320-328. doi: 10.1016/j.bpsc.2017.11.009. Epub 2017 Dec 7.

PMID:
29628064
29.

The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.

van der Straten A, Agot K, Ahmed K, Weinrib R, Browne EN, Manenzhe K, Owino F, Schwartz J, Minnis A; TRIO Study Team.

J Int AIDS Soc. 2018 Mar;21(3):e25094. doi: 10.1002/jia2.25094.

30.

Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.

Minnis AM, Roberts ST, Agot K, Weinrib R, Ahmed K, Manenzhe K, Owino F, van der Straten A; TRIO Study Team.

AIDS Behav. 2018 Aug;22(8):2662-2673. doi: 10.1007/s10461-018-2078-5.

31.

Motivated Reasoning and HIV Risk? Views on Relationships, Trust, and Risk from Young Women in Cape Town, South Africa, and Implications for Oral PrEP.

Hartmann M, McConnell M, Bekker LG, Celum C, Bennie T, Zuma J, van der Straten A.

AIDS Behav. 2018 Nov;22(11):3468-3479. doi: 10.1007/s10461-018-2044-2.

32.

Impact of treatment on resting cerebral blood flow and metabolism in obsessive compulsive disorder: a meta-analysis.

van der Straten AL, Denys D, van Wingen GA.

Sci Rep. 2017 Dec 12;7(1):17464. doi: 10.1038/s41598-017-17593-7.

33.

End-Users' Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa.

Weinrib R, Minnis A, Agot K, Ahmed K, Owino F, Manenzhe K, Cheng H, van der Straten A.

AIDS Behav. 2018 Jan;22(1):133-145. doi: 10.1007/s10461-017-1911-6.

34.

Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.

Lykins WR, Luecke E, Johengen D, van der Straten A, Desai TA.

Drug Deliv Transl Res. 2017 Dec;7(6):805-816. doi: 10.1007/s13346-017-0391-6. Review.

PMID:
28612340
35.

Acceptability and use of a dapivirine vaginal ring in a phase III trial.

Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, Bekker LG, Etima J, Nakyanzi T, Mayo AJ, Katz A, Laborde N, Grossman CI, Soto-Torres L, Palanee-Phillips T, Baeten JM; MTN-020/ASPIRE Study.

AIDS. 2017 May 15;31(8):1159-1167. doi: 10.1097/QAD.0000000000001452. Erratum in: AIDS. 2017 Nov 28;31(18):2563.

36.

How common and frequent is heterosexual anal intercourse among South Africans? A systematic review and meta-analysis.

Owen BN, Elmes J, Silhol R, Dang Q, McGowan I, Shacklett B, Swann EM, van der Straten A, Baggaley RF, Boily MC.

J Int AIDS Soc. 2017 Jan 12;19(1):21162. doi: 10.7448/IAS.20.1.21162.

37.

Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.

Koss CA, Bacchetti P, Hillier SL, Livant E, Horng H, Mgodi N, Mirembe BG, Gomez Feliciano K, Horn S, Liu AY, Glidden DV, Grant RM, Benet LZ, Louie A, van der Straten A, Chirenje ZM, Marrazzo JM, Gandhi M.

AIDS Res Hum Retroviruses. 2017 Aug;33(8):778-783. doi: 10.1089/aid.2016.0202. Epub 2017 Mar 2.

38.

How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda and Zimbabwe.

Musara P, Montgomery ET, Mgodi NM, Woeber K, Akello CA, Hartmann M, Cheng H, Levy L, Katz A, Grossman CI, Chirenje ZM, van der Straten A, Mensch B; Microbicide Trials Network-003D Study Team.

AIDS Behav. 2018 Mar;22(3):877-886. doi: 10.1007/s10461-017-1685-x.

39.

Achieving the optimal vaginal state: using vaginal products and study gels in Uganda, Zimbabwe, and South Africa.

Duby Z, Mensch B, Hartmann M, Montgomery E, Mahaka I, Bekker LG, van der Straten A.

Int J Sex Health. 2017;29(3):247-257. doi: 10.1080/19317611.2017.1297754. Epub 2017 Mar 27.

40.

Misreporting of Product Adherence in the MTN-003/VOICE Trial for HIV Prevention in Africa: Participants' Explanations for Dishonesty.

Montgomery ET, Mensch B, Musara P, Hartmann M, Woeber K, Etima J, van der Straten A.

AIDS Behav. 2017 Feb;21(2):481-491. doi: 10.1007/s10461-016-1609-1.

41.

Adherence and the Lie in a HIV Prevention Clinical Trial.

Stadler J, Scorgie F, van der Straten A, Saethre E.

Med Anthropol. 2016 Nov-Dec;35(6):503-516. Epub 2015 Nov 17.

42.

Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?

Mensch BS, Brown ER, Liu K, Marrazzo J, Chirenje ZM, Gomez K, Piper J, Patterson K, van der Straten A.

AIDS Behav. 2016 Nov;20(11):2654-2661.

43.

Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States.

van der Straten A, Panther L, Laborde N, Hoesley CJ, Cheng H, Husnik MJ, Horn S, Nel A, Soto-Torres L, Chen BA.

AIDS Behav. 2016 Nov;20(11):2644-2653.

44.

Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.

Luecke EH, Cheng H, Woeber K, Nakyanzi T, Mudekunye-Mahaka IC, van der Straten A; MTN-003D Study Team.

J Int AIDS Soc. 2016 May 30;19(1):20875. doi: 10.7448/IAS.19.1.20875. eCollection 2016.

45.

A Tunable, Biodegradable, Thin-Film Polymer Device as a Long-Acting Implant Delivering Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis.

Schlesinger E, Johengen D, Luecke E, Rothrock G, McGowan I, van der Straten A, Desai T.

Pharm Res. 2016 Jul;33(7):1649-56. doi: 10.1007/s11095-016-1904-6. Epub 2016 Mar 14.

46.

Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.

Nel A, Bekker LG, Bukusi E, Hellstrӧm E, Kotze P, Louw C, Martinson F, Masenga G, Montgomery E, Ndaba N, van der Straten A, van Niekerk N, Woodsong C.

PLoS One. 2016 Mar 10;11(3):e0147743. doi: 10.1371/journal.pone.0147743. eCollection 2016.

47.

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.

Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, Makanani B, Pather A, Naidoo L, Husnik M, Richardson BA, Parikh UM, Mellors JW, Marzinke MA, Hendrix CW, van der Straten A, Ramjee G, Chirenje ZM, Nakabiito C, Taha TE, Jones J, Mayo A, Scheckter R, Berthiaume J, Livant E, Jacobson C, Ndase P, White R, Patterson K, Germuga D, Galaska B, Bunge K, Singh D, Szydlo DW, Montgomery ET, Mensch BS, Torjesen K, Grossman CI, Chakhtoura N, Nel A, Rosenberg Z, McGowan I, Hillier S; MTN-020–ASPIRE Study Team.

N Engl J Med. 2016 Dec 1;375(22):2121-2132. Epub 2016 Feb 22.

48.

Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.

van der Straten A, Brown ER, Marrazzo JM, Chirenje MZ, Liu K, Gomez K, Marzinke MA, Piper JM, Hendrix CW; MTN-003 VOICE Protocol Team for Microbicide Trials Network.

J Int AIDS Soc. 2016 Feb 4;19(1):20642. doi: 10.7448/IAS.19.1.20642. eCollection 2016.

49.

Lost in Translation: Language, Terminology, and Understanding of Penile-Anal Intercourse in an HIV Prevention Trial in South Africa, Uganda, and Zimbabwe.

Duby Z, Hartmann M, Mahaka I, Munaiwa O, Nabukeera J, Vilakazi N, Mthembu F, Colvin CJ, Mensch B, van der Straten A.

J Sex Res. 2016 Nov-Dec;53(9):1096-1106. Epub 2015 Nov 13.

50.

Negotiating the use of female-initiated HIV prevention methods in a context of gender-based violence: the narrative of rape.

Hartmann M, Montgomery E, Stadler J, Laborde N, Magazi B, Mathebula F, van der Straten A.

Cult Health Sex. 2016;18(6):611-24. doi: 10.1080/13691058.2015.1101786. Epub 2015 Nov 9.

Supplemental Content

Loading ...
Support Center